ALK.NET: Keyword Density Checker

Total words: 1887 | 2-word phrases: 495 | 3-word phrases: 533 | 4-word phrases: 550

PAGE INFO

Title	Try to keep the title under 60 characters (32 characters) ALK \| Allergy solutions for life
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (61 characters) Celebrating the past and future of allergy solutions for life

ONE WORD PHRASES 309 Words

#	Keyword	Frequency	Density
1	allergy	20	6.47%
2	the	15	4.85%
3	read	15	4.85%
4	of	14	4.53%
5	more	13	4.21%
6	and	13	4.21%
7	in	11	3.56%
8	for	10	3.24%
9	date	10	3.24%
10	alk	9	2.91%

TWO WORD PHRASES 495 Words

#	Keyword	Frequency	Density
1	read more	13	2.63%
2	post date	9	1.82%
3	more post	7	1.41%
4	about alk	5	1.01%
5	of allergy	4	0.81%
6	more about	4	0.81%
7	capital markets	4	0.81%
8	in the	3	0.61%
9	allergy solutions	3	0.61%
10	markets day	3	0.61%
11	board of	3	0.61%
12	with a	3	0.61%
13	about alks	3	0.61%
14	and the	2	0.40%
15	for the	2	0.40%
16	allergy immunotherapy	2	0.40%
17	in on	2	0.40%
18	100 years	2	0.40%
19	company releases	2	0.40%
20	and developed	2	0.40%

THREE WORD PHRASES 533 Words

#	Keyword	Frequency	Density
1	read more post	7	1.31%
2	more post date	7	1.31%
3	read more about	4	0.75%
4	capital markets day	3	0.56%
5	for the treatment	2	0.38%
6	the treatment of	2	0.38%
7	treatment of allergy	2	0.38%
8	more about alks	2	0.38%
9	developed major advances	2	0.38%
10	alk’s capital markets	2	0.38%
11	board of management	2	0.38%
12	day on 4	2	0.38%
13	and developed major	2	0.38%
14	on 4 june	2	0.38%
15	devised and developed	2	0.38%
16	2024 read more	2	0.38%
17	post date 05022024	2	0.38%
18	markets day 2024	2	0.38%
19	the company’s 100	1	0.19%
20	years of hunting	1	0.19%
21	of hunting allergy	1	0.19%
22	hunting allergy vaccines	1	0.19%
23	and the company’s	1	0.19%
24	alk your allergy	1	0.19%
25	about alk and	1	0.19%
26	alk and the	1	0.19%
27	story about alk	1	0.19%
28	fascinating story about	1	0.19%
29	a fascinating story	1	0.19%
30	episodes a fascinating	1	0.19%

FOUR WORD PHRASES 550 Words

#	Keyword	Frequency	Density
1	read more post date	7	1.27%
2	and developed major advances	2	0.36%
3	day on 4 june	2	0.36%
4	capital markets day 2024	2	0.36%
5	the treatment of allergy	2	0.36%
6	more post date 05022024	2	0.36%
7	for the treatment of	2	0.36%
8	read more about alks	2	0.36%
9	devised and developed major	2	0.36%
10	for a vaccine –	1	0.18%
11	a vaccine – a	1	0.18%
12	vaccine – a podcast	1	0.18%
13	alk your allergy what	1	0.18%
14	– a podcast in	1	0.18%
15	the hunt for a	1	0.18%
16	five episodes a fascinating	1	0.18%
17	episodes a fascinating story	1	0.18%
18	hunt for a vaccine	1	0.18%
19	of allergy read now	1	0.18%
20	now the hunt for	1	0.18%
21	read now the hunt	1	0.18%
22	allergy read now the	1	0.18%
23	fascinating story about alk	1	0.18%
24	field of allergy read	1	0.18%
25	the field of allergy	1	0.18%
26	alk’s fascinating development in	1	0.18%
27	about alk’s fascinating development	1	0.18%
28	written about alk’s fascinating	1	0.18%
29	been written about alk’s	1	0.18%
30	has been written about	1	0.18%
31	a fascinating story about	1	0.18%
32	about alk and the	1	0.18%
33	story about alk and	1	0.18%
34	the podcast here alk	1	0.18%
35	hay feveris a widespread	1	0.18%
36	as hay feveris a	1	0.18%
37	known as hay feveris	1	0.18%
38	rhinitispopularly known as hay	1	0.18%
39	allergic rhinitispopularly known as	1	0.18%
40	allergy at a glance	1	0.18%

EXTERNAL LINKS

#	URL	Whois	Check
1	https://alkabello.easycruit.com/	Whois	easycruit.com
2	https://player.skyfish.com/?v=https%3A//video.skyfish.com/943a10db-106f-4de5-882b-15e46428e763/AppleHLS1/stream-315260-58265547.m3u8&media=58265547	Whois	skyfish.com
3	https://www.globenewswire.com/news-release/2024/06/03/2891893/0/en/ALK-presents-positive-phase-3-paediatric-trial-data-offering-new-hope-for-children-with-respiratory-allergies.html	Whois	globenewswire.com
4	https://www.globenewswire.com/news-release/2024/06/03/2892451/0/en/ALK-launches-new-growth-strategy-and-2028-financial-ambitions.html	Whois	globenewswire.com
5	https://www.globenewswire.com/news-release/2024/05/30/2890666/0/en/ALK-s-European-registration-application-for-ITULAZAX-for-paediatric-indication-accepted-for-review.html	Whois	globenewswire.com
6	https://www.globenewswire.com/news-release/2024/05/29/2889626/0/en/Listen-in-on-ALK-s-Capital-Markets-Day-on-4-June-2024.html	Whois	globenewswire.com
7	https://www.globenewswire.com/news-release/2024/05/02/2874560/0/en/ALK-upgrades-its-full-year-revenue-outlook.html	Whois	globenewswire.com
8	https://www.globenewswire.com/news-release/2024/05/02/2874568/0/en/Three-month-interim-report-Q1-2024-unaudited.html	Whois	globenewswire.com
9	https://www.globenewswire.com/news-release/2024/04/24/2868787/0/en/Invitation-to-the-presentation-of-ALK-s-first-quarter-results-on-Friday-3-May-2024.html	Whois	globenewswire.com
10	https://www.globenewswire.com/news-release/2024/04/03/2857061/0/en/Grant-of-share-based-long-term-incentive-instruments-to-members-of-the-Board-of-Management-and-key-employees.html	Whois	globenewswire.com
11	https://www.globenewswire.com/news-release/2024/03/26/2852388/0/en/Save-the-date-for-ALK-s-Capital-Markets-Day-on-4-June-2024.html	Whois	globenewswire.com